Cardioprotective effect of phytosterol stigmasterol supplementation against doxorubicin-induced cardiotoxicity
Folia Morphologica · 2025
DOI: 10.5603/fm.103866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Morphologica, 2025. Verfasst von Ying Wang. Beteiligte Einrichtung: Inner Mongolia Autonomous Region People's Hospital, Department of Hematology, Hohhot, Inner Mongolia, Autonomous Region, China. cfwy1980@outlook.com. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotoxicity, Stigmasterol, Cardiotonic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Stigmasterol, a phytosterol abundantly found in various plantsources, including soybeans and other legumes, plays a significant pharmaceuticalrole due to its pharmacological properties. Research suggests thatstigmasterol exhibits anti-inflammatory, antioxidant, and cholesterol-loweringeffects, making it a promising candidate for managing cardiovascular disorders.In this work, we elucidated the cardioprotective potency of stigmasterol againstdoxorubicin-induced cardiotoxicity in rats.Materials and methods: Hence we have evaluated the potency of stigmasterolsupplementation in preventing doxorubicin-induced cardiotoxicity. Male Wistarrats were treated with doxorubicin (2.5 mg/kg) and supplemented with 25 and50 mg/kg doses of stigmasterol for 14 days. On day 14 of treatment tail-cuff plethysmographywas conducted to assess the hemodynamic parameters. The concentrationsof oxidative stress markers, cardiac function markers, myocardial damagemarkers, and inflammatory biomarkers were assessed in the experimental rats usingthe commercial kits. The heart tissues were subjected to the histopathologicalanalysis. Docking study was also conducted with NF-κB.
Results
The stigmasterol treatment effectively increased the body weight andheart weight and elevated the hemodynamic parameters in doxorubinin-inducedrats. The stigmasterol treatment also decreased the oxidative stress via increasingantioxidants, reduced the cardiac function markers, and decreased the myocardialdamage markers in the doxorubicin-induced rats. Furthermore, the stigmasteroltreatment also reduced the inflammatory markers in the doxorubicin-inducedrats. The cardioprotective properties of the stigmasterol was further supportedby the results of histopathological analysis and docking analysis where it showedexcellent binding affinity for NF-κB.
Conclusions
The results of tail-cuff plethysmography and cardiac tissue histopathologicalanalysis authentically proved the inhibitory effect of stigmasterolagainst doxorubicin-induced cardiotoxicity. To conclude supplementation withphytochemical stigmasterol persuasively ameliorated doxorubicin-induced cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inner Mongolia Autonomous Region People's Hospital, Department of Hematology, Hohhot, Inner Mongolia, Autonomous Region, China. cfwy1980@outlook.com.
ORCID-Profile: Ying Wang
Zitieren
APA
Wang, Y. (2025). Cardioprotective effect of phytosterol stigmasterol supplementation against doxorubicin-induced cardiotoxicity. Folia Morphologica. https://doi.org/10.5603/fm.103866
Vancouver
Wang Y. Cardioprotective effect of phytosterol stigmasterol supplementation against doxorubicin-induced cardiotoxicity. Folia Morphologica. 2025. doi:10.5603/fm.103866
BibTeX
@article{Wang2025,
author = {Wang, Ying},
title = {Cardioprotective effect of phytosterol stigmasterol supplementation against doxorubicin-induced cardiotoxicity},
journal = {Folia Morphologica},
year = {2025},
doi = {10.5603/fm.103866}
}
EUVIMED